Feb 6 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO
* AURINIA ANNOUNCES APPOINTMENT OF COMPANY FOUNDER, DR. RICHARD M. GLICKMAN, AS ITS NEW CHIEF EXECUTIVE OFFICER
* BOARD ACCEPTED RESIGNATION OF CHARLES ROWLAND AS CEO AND AN EXECUTIVE MEMBER OF BOARD, EFFECTIVE IMMEDIATELY Source text for Eikon: ID:nBw9tqsCda Further company coverage: AUP.TO